Your browser doesn't support javascript.
loading
Corrigendum: Assessing potency and binding kinetics of soluble adenylyl cyclase (sAC) inhibitors to maximize therapeutic potential.
Rossetti, Thomas; Ferreira, Jacob; Ghanem, Lubna; Buck, Hannes; Steegborn, Clemens; Myers, Robert W; Meinke, Peter T; Levin, Lonny R; Buck, Jochen.
Afiliación
  • Rossetti T; Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States.
  • Ferreira J; Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States.
  • Ghanem L; Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States.
  • Buck H; Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States.
  • Steegborn C; Department of Biochemistry, University of Bayreuth, Bayreuth, Germany.
  • Myers RW; Tri-Institutional Therapeutics Discovery Institute, New York, NY, United States.
  • Meinke PT; Tri-Institutional Therapeutics Discovery Institute, New York, NY, United States.
  • Levin LR; Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States.
  • Buck J; Department of Pharmacology, Weill Cornell Medicine, New York, NY, United States.
Front Physiol ; 14: 1163389, 2023.
Article en En | MEDLINE | ID: mdl-36950298
ABSTRACT
[This corrects the article DOI 10.3389/fphys.2022.1013845.].
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Physiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Physiol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...